February 2014 - Volume 20 - Issue 2 - Contributor Index

Alphabetical Search
Q
U
X
Z
Author:
Abreu, Maria

Malignancy and Mortality in Pediatric Patients with Inflammatory Bowel Disease: A Multinational Study from the Porto Pediatric IBD Group

de Ridder, Lissy; Turner, Dan; Wilson, David C.; More

Inflammatory Bowel Diseases. 20(2):291-300, February 2014.

Comparison of Outcomes Parameters for Induction of Remission in New Onset Pediatric Crohn's Disease: Evaluation of the Porto IBD Group “Growth Relapse and Outcomes with Therapy”...

Levine, Arie; Turner, Dan; Pfeffer Gik, Tamar; More

Inflammatory Bowel Diseases. 20(2):278-285, February 2014.

Challenges in Designing a National Surveillance Program for Inflammatory Bowel Disease in the United States

Long, Millie D.; Hutfless, Susan; Kappelman, Michael D.; More

Inflammatory Bowel Diseases. 20(2):398-415, February 2014.

T-Cell Profiling and the Immunodiagnosis of Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease

Arias-Guillén, Miguel; Riestra, Sabino; de Francisco, Ruth; More

Inflammatory Bowel Diseases. 20(2):329-338, February 2014.

Infliximab Restores the Dysfunctional Matrix Remodeling Protein and Growth Factor Gene Expression in Patients with Inflammatory Bowel Disease

de Bruyn, Magali; Machiels, Kathleen; Vandooren, Jennifer; More

Inflammatory Bowel Diseases. 20(2):339-352, February 2014.

FOXE1 and SYNE1 Genes Hypermethylation Panel as Promising Biomarker in Colitis-associated Colorectal Neoplasia

Papadia, Cinzia; Louwagie, Joost; Del Rio, Paolo; More

Inflammatory Bowel Diseases. 20(2):271-277, February 2014.

Challenges in Designing a National Surveillance Program for Inflammatory Bowel Disease in the United States

Long, Millie D.; Hutfless, Susan; Kappelman, Michael D.; More

Inflammatory Bowel Diseases. 20(2):398-415, February 2014.

FOXE1 and SYNE1 Genes Hypermethylation Panel as Promising Biomarker in Colitis-associated Colorectal Neoplasia

Papadia, Cinzia; Louwagie, Joost; Del Rio, Paolo; More

Inflammatory Bowel Diseases. 20(2):271-277, February 2014.

T-Cell Profiling and the Immunodiagnosis of Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease

Arias-Guillén, Miguel; Riestra, Sabino; de Francisco, Ruth; More

Inflammatory Bowel Diseases. 20(2):329-338, February 2014.

Challenges in Designing a National Surveillance Program for Inflammatory Bowel Disease in the United States

Long, Millie D.; Hutfless, Susan; Kappelman, Michael D.; More

Inflammatory Bowel Diseases. 20(2):398-415, February 2014.

FOXE1 and SYNE1 Genes Hypermethylation Panel as Promising Biomarker in Colitis-associated Colorectal Neoplasia

Papadia, Cinzia; Louwagie, Joost; Del Rio, Paolo; More

Inflammatory Bowel Diseases. 20(2):271-277, February 2014.

Infliximab Restores the Dysfunctional Matrix Remodeling Protein and Growth Factor Gene Expression in Patients with Inflammatory Bowel Disease

de Bruyn, Magali; Machiels, Kathleen; Vandooren, Jennifer; More

Inflammatory Bowel Diseases. 20(2):339-352, February 2014.

Challenges in Designing a National Surveillance Program for Inflammatory Bowel Disease in the United States

Long, Millie D.; Hutfless, Susan; Kappelman, Michael D.; More

Inflammatory Bowel Diseases. 20(2):398-415, February 2014.

FOXE1 and SYNE1 Genes Hypermethylation Panel as Promising Biomarker in Colitis-associated Colorectal Neoplasia

Papadia, Cinzia; Louwagie, Joost; Del Rio, Paolo; More

Inflammatory Bowel Diseases. 20(2):271-277, February 2014.

Malignancy and Mortality in Pediatric Patients with Inflammatory Bowel Disease: A Multinational Study from the Porto Pediatric IBD Group

de Ridder, Lissy; Turner, Dan; Wilson, David C.; More

Inflammatory Bowel Diseases. 20(2):291-300, February 2014.

Effects of Infliximab Retreatment After Consecutive Discontinuation of Infliximab and Adalimumab in Refractory Crohn's Disease

Brandse, Johannan F.; Peters, Charlotte P.; Gecse, Krisztina B.; More

Inflammatory Bowel Diseases. 20(2):251-258, February 2014.

Infliximab Restores the Dysfunctional Matrix Remodeling Protein and Growth Factor Gene Expression in Patients with Inflammatory Bowel Disease

de Bruyn, Magali; Machiels, Kathleen; Vandooren, Jennifer; More

Inflammatory Bowel Diseases. 20(2):339-352, February 2014.

Challenges in Designing a National Surveillance Program for Inflammatory Bowel Disease in the United States

Long, Millie D.; Hutfless, Susan; Kappelman, Michael D.; More

Inflammatory Bowel Diseases. 20(2):398-415, February 2014.

Malignancy and Mortality in Pediatric Patients with Inflammatory Bowel Disease: A Multinational Study from the Porto Pediatric IBD Group

de Ridder, Lissy; Turner, Dan; Wilson, David C.; More

Inflammatory Bowel Diseases. 20(2):291-300, February 2014.

The Body Image Scale: A Simple and Valid Tool for Assessing Body Image Dissatisfaction in Inflammatory Bowel Disease

McDermott, Edel; Moloney, Jenny; Rafter, Niamh; More

Inflammatory Bowel Diseases. 20(2):286-290, February 2014.

Immunization Rates and Vaccine Beliefs Among Patients with Inflammatory Bowel Disease: An Opportunity for Improvement

Wasan, Sharmeel K.; Calderwood, Audrey H.; Long, Millie D.; More

Inflammatory Bowel Diseases. 20(2):246-250, February 2014.

T-Cell Profiling and the Immunodiagnosis of Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease

Arias-Guillén, Miguel; Riestra, Sabino; de Francisco, Ruth; More

Inflammatory Bowel Diseases. 20(2):329-338, February 2014.

Challenges in Designing a National Surveillance Program for Inflammatory Bowel Disease in the United States

Long, Millie D.; Hutfless, Susan; Kappelman, Michael D.; More

Inflammatory Bowel Diseases. 20(2):398-415, February 2014.

Author:
Coarse, Jason

Challenges in Designing a National Surveillance Program for Inflammatory Bowel Disease in the United States

Long, Millie D.; Hutfless, Susan; Kappelman, Michael D.; More

Inflammatory Bowel Diseases. 20(2):398-415, February 2014.

FOXE1 and SYNE1 Genes Hypermethylation Panel as Promising Biomarker in Colitis-associated Colorectal Neoplasia

Papadia, Cinzia; Louwagie, Joost; Del Rio, Paolo; More

Inflammatory Bowel Diseases. 20(2):271-277, February 2014.

Malignancy and Mortality in Pediatric Patients with Inflammatory Bowel Disease: A Multinational Study from the Porto Pediatric IBD Group

de Ridder, Lissy; Turner, Dan; Wilson, David C.; More

Inflammatory Bowel Diseases. 20(2):291-300, February 2014.

The Body Image Scale: A Simple and Valid Tool for Assessing Body Image Dissatisfaction in Inflammatory Bowel Disease

McDermott, Edel; Moloney, Jenny; Rafter, Niamh; More

Inflammatory Bowel Diseases. 20(2):286-290, February 2014.

Effects of Infliximab Retreatment After Consecutive Discontinuation of Infliximab and Adalimumab in Refractory Crohn's Disease

Brandse, Johannan F.; Peters, Charlotte P.; Gecse, Krisztina B.; More

Inflammatory Bowel Diseases. 20(2):251-258, February 2014.

Malignancy and Mortality in Pediatric Patients with Inflammatory Bowel Disease: A Multinational Study from the Porto Pediatric IBD Group

de Ridder, Lissy; Turner, Dan; Wilson, David C.; More

Inflammatory Bowel Diseases. 20(2):291-300, February 2014.

Infliximab Restores the Dysfunctional Matrix Remodeling Protein and Growth Factor Gene Expression in Patients with Inflammatory Bowel Disease

de Bruyn, Magali; Machiels, Kathleen; Vandooren, Jennifer; More

Inflammatory Bowel Diseases. 20(2):339-352, February 2014.

T-Cell Profiling and the Immunodiagnosis of Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease

Arias-Guillén, Miguel; Riestra, Sabino; de Francisco, Ruth; More

Inflammatory Bowel Diseases. 20(2):329-338, February 2014.

Infliximab Restores the Dysfunctional Matrix Remodeling Protein and Growth Factor Gene Expression in Patients with Inflammatory Bowel Disease

de Bruyn, Magali; Machiels, Kathleen; Vandooren, Jennifer; More

Inflammatory Bowel Diseases. 20(2):339-352, February 2014.

Malignancy and Mortality in Pediatric Patients with Inflammatory Bowel Disease: A Multinational Study from the Porto Pediatric IBD Group

de Ridder, Lissy; Turner, Dan; Wilson, David C.; More

Inflammatory Bowel Diseases. 20(2):291-300, February 2014.

FOXE1 and SYNE1 Genes Hypermethylation Panel as Promising Biomarker in Colitis-associated Colorectal Neoplasia

Papadia, Cinzia; Louwagie, Joost; Del Rio, Paolo; More

Inflammatory Bowel Diseases. 20(2):271-277, February 2014.

FOXE1 and SYNE1 Genes Hypermethylation Panel as Promising Biomarker in Colitis-associated Colorectal Neoplasia

Papadia, Cinzia; Louwagie, Joost; Del Rio, Paolo; More

Inflammatory Bowel Diseases. 20(2):271-277, February 2014.

The Body Image Scale: A Simple and Valid Tool for Assessing Body Image Dissatisfaction in Inflammatory Bowel Disease

McDermott, Edel; Moloney, Jenny; Rafter, Niamh; More

Inflammatory Bowel Diseases. 20(2):286-290, February 2014.

Author:
Dubinsky, Marla

T-Cell Profiling and the Immunodiagnosis of Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease

Arias-Guillén, Miguel; Riestra, Sabino; de Francisco, Ruth; More

Inflammatory Bowel Diseases. 20(2):329-338, February 2014.

Comparison of Outcomes Parameters for Induction of Remission in New Onset Pediatric Crohn's Disease: Evaluation of the Porto IBD Group “Growth Relapse and Outcomes with Therapy”...

Levine, Arie; Turner, Dan; Pfeffer Gik, Tamar; More

Inflammatory Bowel Diseases. 20(2):278-285, February 2014.

Effects of Infliximab Retreatment After Consecutive Discontinuation of Infliximab and Adalimumab in Refractory Crohn's Disease

Brandse, Johannan F.; Peters, Charlotte P.; Gecse, Krisztina B.; More

Inflammatory Bowel Diseases. 20(2):251-258, February 2014.

Malignancy and Mortality in Pediatric Patients with Inflammatory Bowel Disease: A Multinational Study from the Porto Pediatric IBD Group

de Ridder, Lissy; Turner, Dan; Wilson, David C.; More

Inflammatory Bowel Diseases. 20(2):291-300, February 2014.

Immunization Rates and Vaccine Beliefs Among Patients with Inflammatory Bowel Disease: An Opportunity for Improvement

Wasan, Sharmeel K.; Calderwood, Audrey H.; Long, Millie D.; More

Inflammatory Bowel Diseases. 20(2):246-250, February 2014.

Author:
Feagan, Brian

Infliximab Restores the Dysfunctional Matrix Remodeling Protein and Growth Factor Gene Expression in Patients with Inflammatory Bowel Disease

de Bruyn, Magali; Machiels, Kathleen; Vandooren, Jennifer; More

Inflammatory Bowel Diseases. 20(2):339-352, February 2014.

Fecal Hemoglobin and Calprotectin Are Equally Effective in Identifying Patients with Inflammatory Bowel Disease with Active Endoscopic Inflammation

Mooiweer, Erik; Fidder, Herma H.; Siersema, Peter D.; More

Inflammatory Bowel Diseases. 20(2):307-314, February 2014.

Author:
Finnby, Lenne

Comparison of Outcomes Parameters for Induction of Remission in New Onset Pediatric Crohn's Disease: Evaluation of the Porto IBD Group “Growth Relapse and Outcomes with Therapy”...

Levine, Arie; Turner, Dan; Pfeffer Gik, Tamar; More

Inflammatory Bowel Diseases. 20(2):278-285, February 2014.

FOXE1 and SYNE1 Genes Hypermethylation Panel as Promising Biomarker in Colitis-associated Colorectal Neoplasia

Papadia, Cinzia; Louwagie, Joost; Del Rio, Paolo; More

Inflammatory Bowel Diseases. 20(2):271-277, February 2014.

Role of Regulatory B Cells in Chronic Intestinal Inflammation: Association with Pathogenesis of Crohn's Disease

Oka, Akihiko; Ishihara, Shunji; Mishima, Yoshiyuki; More

Inflammatory Bowel Diseases. 20(2):315-328, February 2014.

T-Cell Profiling and the Immunodiagnosis of Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease

Arias-Guillén, Miguel; Riestra, Sabino; de Francisco, Ruth; More

Inflammatory Bowel Diseases. 20(2):329-338, February 2014.

Effects of Infliximab Retreatment After Consecutive Discontinuation of Infliximab and Adalimumab in Refractory Crohn's Disease

Brandse, Johannan F.; Peters, Charlotte P.; Gecse, Krisztina B.; More

Inflammatory Bowel Diseases. 20(2):251-258, February 2014.

Challenges in Designing a National Surveillance Program for Inflammatory Bowel Disease in the United States

Long, Millie D.; Hutfless, Susan; Kappelman, Michael D.; More

Inflammatory Bowel Diseases. 20(2):398-415, February 2014.

FOXE1 and SYNE1 Genes Hypermethylation Panel as Promising Biomarker in Colitis-associated Colorectal Neoplasia

Papadia, Cinzia; Louwagie, Joost; Del Rio, Paolo; More

Inflammatory Bowel Diseases. 20(2):271-277, February 2014.

Malignancy and Mortality in Pediatric Patients with Inflammatory Bowel Disease: A Multinational Study from the Porto Pediatric IBD Group

de Ridder, Lissy; Turner, Dan; Wilson, David C.; More

Inflammatory Bowel Diseases. 20(2):291-300, February 2014.

Challenges in Designing a National Surveillance Program for Inflammatory Bowel Disease in the United States

Long, Millie D.; Hutfless, Susan; Kappelman, Michael D.; More

Inflammatory Bowel Diseases. 20(2):398-415, February 2014.

Malignancy and Mortality in Pediatric Patients with Inflammatory Bowel Disease: A Multinational Study from the Porto Pediatric IBD Group

de Ridder, Lissy; Turner, Dan; Wilson, David C.; More

Inflammatory Bowel Diseases. 20(2):291-300, February 2014.

Challenges in Designing a National Surveillance Program for Inflammatory Bowel Disease in the United States

Long, Millie D.; Hutfless, Susan; Kappelman, Michael D.; More

Inflammatory Bowel Diseases. 20(2):398-415, February 2014.

Role of Regulatory B Cells in Chronic Intestinal Inflammation: Association with Pathogenesis of Crohn's Disease

Oka, Akihiko; Ishihara, Shunji; Mishima, Yoshiyuki; More

Inflammatory Bowel Diseases. 20(2):315-328, February 2014.

Effects of Infliximab Retreatment After Consecutive Discontinuation of Infliximab and Adalimumab in Refractory Crohn's Disease

Brandse, Johannan F.; Peters, Charlotte P.; Gecse, Krisztina B.; More

Inflammatory Bowel Diseases. 20(2):251-258, February 2014.

Challenges in Designing a National Surveillance Program for Inflammatory Bowel Disease in the United States

Long, Millie D.; Hutfless, Susan; Kappelman, Michael D.; More

Inflammatory Bowel Diseases. 20(2):398-415, February 2014.

Immunization Rates and Vaccine Beliefs Among Patients with Inflammatory Bowel Disease: An Opportunity for Improvement

Wasan, Sharmeel K.; Calderwood, Audrey H.; Long, Millie D.; More

Inflammatory Bowel Diseases. 20(2):246-250, February 2014.

Challenges in Designing a National Surveillance Program for Inflammatory Bowel Disease in the United States

Long, Millie D.; Hutfless, Susan; Kappelman, Michael D.; More

Inflammatory Bowel Diseases. 20(2):398-415, February 2014.

Role of Regulatory B Cells in Chronic Intestinal Inflammation: Association with Pathogenesis of Crohn's Disease

Oka, Akihiko; Ishihara, Shunji; Mishima, Yoshiyuki; More

Inflammatory Bowel Diseases. 20(2):315-328, February 2014.

The Body Image Scale: A Simple and Valid Tool for Assessing Body Image Dissatisfaction in Inflammatory Bowel Disease

McDermott, Edel; Moloney, Jenny; Rafter, Niamh; More

Inflammatory Bowel Diseases. 20(2):286-290, February 2014.

Challenges in Designing a National Surveillance Program for Inflammatory Bowel Disease in the United States

Long, Millie D.; Hutfless, Susan; Kappelman, Michael D.; More

Inflammatory Bowel Diseases. 20(2):398-415, February 2014.